NCT01516242View on ClinicalTrials.gov

Evaluation of Safety and Parameters of Application Technique

CompletedOBSERVATIONAL
Enrollment

4,819

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Delivery Systems
Interventions
OTHER

No treatment given

Collection of data about patients with type 1 diabetes or type 2 diabetes treated with insulin changing their insulin administration from syringe to a insulin delivery system based on completion of questionaire

Trial Locations (1)

811 05

Novo Nordisk Investigational Site, Bratislava

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY